The present study reports changes in synaptic function and plasticity [long-term potentiation (LTP)] in a recently developed mouse model of Alzheimer's disease (CRND8 line) harboring a double amyloid precursor protein mutation (APP swe/ind ). In 9-week-old preplaque transgenic (Tg) mice brain slices, basal synaptic function in the hippocampal CA1 area was unchanged. Only one of three different LTP induction protocols revealed early influence of genotype on synaptic plasticity. By 20 weeks of age, there were numerous plaques in the hippocampus from Tg mice associated with more robust evidence for genotype-related effects in synaptic function. Field potential maximum slope was consistently decreased and LTP was increased, irrespective of the stimulation protocol used. In addition, there was clear evidence of increased synaptic excitability in Tg mice. Furthermore, the maximum amplitude of evoked IPSCs was decreased whereas the maximum amplitude of evoked EPSCs was increased in 20-week-old Tg mice. Collectively, these results suggest a number of APP genotype-related changes in the fine-tuning of the CA1 area circuitry, some of which are likely to contribute to the pathology-dependent effects on LTP observed in CRND8 mice.
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The development of animal models of Alzheimer's disease (AD) that bear all the relevant pathological hallmarks of the disease in an accelerated time frame will help to better understand an illness that affects an increasing percentage of the population (for review see Seabrook & Rosahl, 1999) . AD is characterized by a progressive impairment of cognitive and emotional function, ultimately resulting in death. The behavioral changes are associated with a loss of both neurons and synapses and a massive accumulation of amyloid plaques and neurofibrillary tangles in brain structures such as the cortex and the hippocampus (for review see Arnold, 2000) . One theory suggests that AD results from the cerebral accumulation and cytotoxicity of amyloid ␤-protein (A␤, for review see Selkoe, 2000) . A␤ is found mainly in the brain in two forms that are the product of proteolytic cleavage of ␤-amyloid precursor protein (APP): a 40-amino-acid long peptide (A␤ 40 ) and a 42-amino-acid-long peptide (A␤ 42 ). Five different mutations of the APP gene are known to lead to AD in humans (Hardy, 1997). All these mutations induce an increase in A␤ production, especially A␤ 42 that is known to accumulate in senile plaques.
In recent years there has been a proliferation of transgenic (Tg) manipulations in mice, each designed to mimic the pathological hallmarks of AD. While there have been many differences in approach, the ultimate goal has been, invariably, to recapitulate the disease process culminating in the deposition of amyloid peptides in brain and in a manner consistent with the plaque depositions seen in human brain. The most successful of these mod-1 To whom correspondence should be addressed. Fax: (908) 
